Area of research
Epidemiology · Cancer Research
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Protease and Inhibitor Mechanisms, Skin and Cellular Biology Research, and Peptidase Inhibition and Analysis.
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality
Patient-reported outcome measures for use in patients with alpha-1-antitrypsin deficiency: results of a systematic selection process
Alpha‐1 Antitrypsin Inclusions Sequester <scp>GRP78</scp> in a Bile Acid–Inducible Manner
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
Modern therapeutic approaches to liver-related disorders
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Liver – master and servant of serum proteome
Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE)
Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver